CMS Raises Maximum Rates of Commissions
For the 5th year in a row, CMS has raised the maximum rates of Broker and Agent commissions for Medicare Advantage Plans and Prescription Drug Plans. Here are some of the highlights.
Analysis – The Medicare Part D 2020 Landscape
The Centers for Medicare & Medicaid Services (CMS) recently released premium and cost-sharing information for Part D plans for the 2020 calendar year. Below are the highlights of a preliminary analysis.
The Future of Social Security?
The government currently has no plan for what to do when the money runs short. What are the current possibilities in play? Here is Dr. Steven Weisbart, Chief Economist at the Insurance Information Institute.
CMS Streamlines Medicaid Review Process, Reduces in Approval Times
“With faster processing times and earlier communication, states now have much greater ability to manage their programs in an effective and predictable manner,” said CMS Administrator Seema Verma. “We want to ease bureaucratic requirements for both states and our own staff so that we can focus those resources on improving health outcomes rather than pushing paperwork.”
Medicare Advantage Prior Authorization and Step Therapy for Part B Drugs
Today, the Centers for Medicare & Medicaid Services (CMS) introduced much-needed competition and negotiation into the market for physician-administered and other Part B medications that will result in better deals and lower drug costs for patients.
Medicare Part D premiums continue to decline in 2019
Today, the Centers for Medicare & Medicaid Services (CMS) announced that, for the second year in a row, the average basic premium for a Medicare Part D prescription drug plan in 2019 is projected to decline.